Konstantin Adamsky

Director/Board Member at FILAMENT HEALTH CORP.

53 year

Health Technology

Consumer Services

Profile

Konstantin Adamsky is currently the Chief Executive Officer at Negev Labs and an Independent Director at Filament Health Corp.
He previously worked as the Co-Chief Executive Officer & Director at Targia Pharmaceuticals Ltd.
in 2016, Vice President-Operations at Regenera Pharma Ltd.
from 2017 to 2020, and as VP Operations & Technology at Levco Pharmaceuticals Ltd.
He holds a doctorate degree from the Weizmann Institute of Science.

Konstantin Adamsky active positions

Companies	Position	Start
FILAMENT HEALTH CORP.	Director/Board Member	2022-08-22

All active positions of Konstantin Adamsky

Former positions of Konstantin Adamsky

Companies	Position	End
Regenera Pharma Ltd. Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Regenera Pharma Ltd. develops a novel drug candidate, RPH201 for neurological indications. It also focuses on developing a treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), the most common cause of sudden optic nerve-related vison loss in older people. The company is headquartered in Ness-Ziona, Israel.	Chief Executive Officer	2017-07-31
Levco Pharmaceuticals Ltd.	Chief Operating Officer	-

See the detail of Konstantin Adamsky's experience

Training of Konstantin Adamsky

Weizmann Institute of Science

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Konstantin Adamsky's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
FILAMENT HEALTH CORP.	Health Technology

Private companies	2
Regenera Pharma Ltd. Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Regenera Pharma Ltd. develops a novel drug candidate, RPH201 for neurological indications. It also focuses on developing a treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), the most common cause of sudden optic nerve-related vison loss in older people. The company is headquartered in Ness-Ziona, Israel.	Health Technology
Levco Pharmaceuticals Ltd.